Ayrignac, Xavier http://orcid.org/0000-0003-3834-2981
Rigau, Valérie
Lhermitte, Benoit
Vincent, Thierry
de Champfleur, Nicolas Menjot
Carra-Dalliere, Clarisse
Charif, Mahmoud
Collongues, Nicolas
de Seze, Jérôme
Hebbadj, Sonia
Ahle, Guido
Oesterlé, Hélène
Cotton, François
Durand-Dubief, Françoise
Marignier, Romain
Vukusic, Sandra
Taithe, Frédéric
Cohen, Mikael
Guennoc, Anne-Marie
Kerbrat, Anne
Edan, Gilles
Carsin-Nicol, Béatrice
Allou, Thibaut
Sablot, Denis
Thouvenot, Eric
Ruet, Aurélie
Magy, Laurent
Boncoeur-Martel, Marie-Paule
Labauge, Pierre
Kremer, Stéphane
Article History
Received: 28 January 2019
Revised: 12 April 2019
Accepted: 16 April 2019
First Online: 23 April 2019
Compliance with ethical standards
:
: Xavier Ayrignac has received consulting and lecturing fees, travel grants and research support from Bayer-Schering, Biogen Idec, Genzyme, Novartis, Merck Serono, Roche, and Teva Pharma. Valérie Rigau reports no disclosure relevant to this manuscript. Benoit Lhermitte reports no disclosure relevant to this manuscript. Thierry Vincent reports no disclosure relevant to this manuscript. Nicolas Menjot de Champfleur reports no disclosure relevant to this manuscript. Clarisse Carra-Dalliere reports no disclosure relevant to this manuscript. Mahmoud Charif reports no disclosure relevant to this manuscript. Nicolas Collongues reports no disclosure relevant to this manuscript. Jérôme de Seze reports no disclosure relevant to this manuscript. Sonia Hebbadj reports no disclosure relevant to this manuscript. Guido Ahle reports no disclosure relevant to this manuscript. Hélène Oesterlé reports no disclosure relevant to this manuscript. François Cotton reports no disclosure relevant to this manuscript. Françoise Durand-Dubief reports no disclosure relevant to this manuscript. Romain Marignier serves on scientific advisory board for MedImmune and has received funding for travel and honoraria from Biogen Idec, Merck Serono, Novartis, Sanofi-Genzyme and Teva. Frédéric Taithe reports no disclosure relevant to this manuscript. Mikael Cohen reports no disclosure relevant to this manuscript. Anne-Marie Guennoc reports no disclosure relevant to this manuscript. Anne Kerbrat reports no disclosure relevant to this manuscript. Gilles Edan reports no disclosure relevant to this manuscript. Béatrice Carsin-Nicol reports no disclosure relevant to this manuscript. Thibaut Allou reports no disclosure relevant to this manuscript. Denis Sablot reports no disclosure relevant to this manuscript. Eric Thouvenot reports no disclosure relevant to this manuscript. Aurélie Ruet or her institution received research grants and/or consulting fees from Novartis, Biogen, Merck-Serono, Bayer Healthcare, Roche, Teva, and Genzyme unrelated to the submitted work. Laurent Magy has received Honoraria, housing and consultancies from CSL Behring, Biogen, Teva Pharma, Octapharma, Pharnext, Sanofi Genzyme, Novartis. Marie-Paule Boncoeur-Martel reports no disclosure relevant to this manuscript. Pierre Labauge reports no disclosure relevant to this manuscript. Stéphane Kremer reports no disclosure relevant to this manuscript.
: The study was approved by Montpellier University Hospital Ethical Committee (Q-2017-03-02) and was registered on ClinicalTrial.gov (NCT03121105).